Persistent Asset Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.5K Hold
1,023
– – ﹤0.01% 702
2026
Q2
$47.3K Buy
+1,023
New +$2.99K 0.01% 472
2026
Q1
– Sell
-862
Closed -$34 – 371
2025
Q4
$34 Buy
862
+169
+24% +$488 ﹤0.01% 356
2025
Q3
$27.7K Buy
+693
New +$1.93K 0.02% 199

Other funds holding EDIT

Persistent Asset Partners's EDIT Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Editas Medicine (EDIT) in Q3 2026: 38,805 shares worth $100K. The stake represents 0.03% of the portfolio and ranks #285 among its holdings.

218 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Persistent Asset Partners held 38,805 shares of Editas Medicine worth $100K as of Q3 2026.
  • Editas Medicine was a new Persistent Asset Partners position in Q3 2026.
  • Editas Medicine made up 0.03% of Persistent Asset Partners's portfolio in Q3 2026, its #285 holding.
  • 218 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.